Miró Oscar, López Sònia, Pedrol Enric, Rodríguez-Santiago Benjamín, Martínez Esteban, Soler Anna, Milinkovic Ana, Casademont Jordi, Nunes Virginia, Gatell Josep M, Cardellach Francesc
Mitochondrial Research Lab, Muscle Research Unit, Dept. of Internal Medicine, (IDIBAPS), School of Medicine, Univ. of Barcelona, Spain.
Antivir Ther. 2003 Aug;8(4):333-8.
The main objective of the present study was to ascertain if mitochondrial DNA (mtDNA) depletion as reported in HIV-infected patients with highly active antiretroviral therapy (HAART)-related lipodystrophy (LD) implies any degree of mitochondrial respiratory chain (MRC) dysfunction. For this purpose, we evaluated HIV patients on different HAART schedules with LD (group A; n=12) and on HAART but without LD (group B; n=12), and untreated HIV-infected patients as controls (group C; n=24). mtDNA content was determined on peripheral blood mononuclear cells (PBMCs) with a real-time PCR method. Complex II, III and IV activities of the MRC were simultaneously measured spectrophotometrically, as were spontaneous and stimulated oxygen consumption by PBMCs. Compared to controls (group C, 100%), patients with LD (group A) showed a decreased mtDNA content (54%, P<0.001), which was associated with a decline in complex III (62%, P<0.05) and IV activity (69%, P<0.05) (both complexes partially encoded by mtDNA), but not in complex II activity (exclusively encoded by nuclear DNA). Patients in group B showed a similar pattern of mitochondrial dysfunction but to a lesser extent and without statistical significance. Respiratory activities in both treated groups (A and B) did not differ in comparison with controls. We conclude that mtDNA depletion occurring during HAART is associated with deficiencies in MRC complexes partially encoded by mtDNA, which are detectable by PBMCs. Presented in 'Late Breakers and Hot Topics' session at 6th International Congress on Drug Therapy in HIV Infection, Glasgow, UK, 17-21 November 2002.
本研究的主要目的是确定在接受高效抗逆转录病毒治疗(HAART)且患有与脂肪代谢障碍(LD)相关的HIV感染患者中所报道的线粒体DNA(mtDNA)耗竭是否意味着线粒体呼吸链(MRC)存在任何程度的功能障碍。为此,我们评估了处于不同HAART治疗方案下且患有LD的HIV患者(A组;n = 12)、接受HAART治疗但未患LD的患者(B组;n = 12)以及未接受治疗的HIV感染患者作为对照(C组;n = 24)。采用实时PCR方法测定外周血单个核细胞(PBMC)中的mtDNA含量。用分光光度法同时测定MRC的复合物II、III和IV的活性,以及PBMC的自发和刺激后的氧消耗量。与对照组(C组,100%)相比,患有LD的患者(A组)mtDNA含量降低(54%,P < 0.001),这与复合物III活性下降(62%,P < 0.05)和复合物IV活性下降(69%,P < 0.05)相关(这两种复合物部分由mtDNA编码),但与复合物II活性无关(仅由核DNA编码)。B组患者表现出类似的线粒体功能障碍模式,但程度较轻且无统计学意义。两个治疗组(A组和B组)的呼吸活性与对照组相比无差异。我们得出结论,HAART治疗期间发生的mtDNA耗竭与部分由mtDNA编码的MRC复合物缺陷相关,PBMC可检测到这些缺陷。于2002年11月17 - 21日在英国格拉斯哥举行的第6届HIV感染药物治疗国际大会的‘最新进展与热点话题’会议上发表。